SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-130483
Filing Date
2023-12-29
Accepted
2023-12-29 16:15:39
Documents
1
Period of Report
2023-12-28

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2333942-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2333942-1_4seq1.xml 4 4495
  Complete submission text file 0001104659-23-130483.txt   6092
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Issuer) CIK: 0001012477 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O FORTY SEVEN, INC. 1490 O'BRIEN DRIVE, SUITE A MENLO PARK CA 94025
Business Address
McCamish Mark Anthony (Reporting) CIK: 0001390798 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37977 | Film No.: 231527856